Ads
related to: kadcyla- How KADCYLA® May Work
View The Safety Of KADCYLA® And How
The Treatment Is Thought To Work.
- Side Effects & Tips
Understand Potential Side Effects
When Taking KADCYLA® As A Treatment
- HERConnection Support
Discover A Free Support Program For
Patients Currently Taking KADCYLA®.
- Questions For Your Doctor
Find Important Prescribing And
Safety Questions To Ask Here.
- Taking KADCYLA®
Learn How KADCYLA® Is Given & Ask
Your Doctor If It Is Right For You.
- Support and Resources
Find Out More About Patient
Support and Resources.
- How KADCYLA® May Work
Search results
Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation
Zacks via Yahoo Finance· 5 hours agoRoche's (RHHBY) inavolisib gets Breakthrough Therapy Designation in the United States for advanced...
Seagen's (SGEN) Breast Cancer Study on Tuksya Combo Meets Goal
Zacks via Yahoo Finance· 9 months agoSeagen Inc. SGEN announced positive top-line results from its late-stage HER2CLIMB-02 study,...
Seagen's breast cancer therapy succeeds in late-stage study
Reuters via Yahoo News· 9 months agoPfizer in March agreed to acquire Seagen and its targeted therapies in a $43 billion deal to help...
Roche sceptical about investing more in 'guided-missile' ADC cancer drugs
Reuters via Yahoo News· 2 years agoMANNHEIM (Reuters) -Roche remains sceptical about investing more in antibody-drug conjugates (ADCs),...
ImmunoGen (IMGN) Q2 Earnings and Revenues Miss Estimates
Zacks via Yahoo Finance· 2 years agoImmunoGen, Inc. IMGN incurred a loss of 24 cents per share for second-quarter 2022, wider than the...
Roche (RHHBY) Q3 Revenues Dip on Lower COVID-19-Related Sales
Zacks via Yahoo Finance· 2 years agoSwiss pharma giant Roche Holding AG’s RHHBY third-quarter revenues declined 6% to CHF 14.7 billion...
Roche's (RHHBY) 2022 Core Earnings Grow, 2023 Outlook Dismal
Zacks via Yahoo Finance· 1 year agoRoche Holding AG’s RHHBY performance in 2022 was pretty average, as the demand for COVID-19 products...
ImmunoGen (IMGN) Ovarian Cancer Drug BLA Gets Priority Review
Zacks via Yahoo Finance· 2 years agoImmunoGen (IMGN) gets priority review from the FDA for the BLA seeking approval for its lead...
Puma Biotech (PBYI) Q4 Loss Wider Than Expected, Sales Top
Zacks via Yahoo Finance· 1 year agoPuma Biotechnology PBYI reported fourth-quarter 2022 loss of 12 cents per share, which was wider...
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Zacks via Yahoo Finance· 2 years agoShares of Puma Biotechnology PBYI were up 17.4% at market close on Aug 5, following the earnings...
Ads
related to: kadcyla